Patents Assigned to ZHEJIANG JIANFENG-YIEN BIOTECHNOLOGY CO., LTD.
  • Heterocycle compounds and uses thereof
    Patent number: 10844074
    Abstract: Compounds having the general formula (I) and pharmaceutical compositions that can be used as Bruton's Tyrosine Kinase (BTK), ITK, JAK3, and selective mutant epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitor and their uses in the treatment of related diseases and disorders such as cancer.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: November 24, 2020
    Assignee: ZHEJIANG JIANFENG-YIEN BIOTECHNOLOGY CO., LTD.
    Inventors: Haixiao Zhai, Fan Wu, Zhanggui Wu
  • Thieno-pyrimidine derivatives and uses thereof
    Patent number: 10829495
    Abstract: Compounds having the general formula I or III, ad pharmaceutical compositions comprising the same. The compounds of the present invention are useful as selective mutant epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitor, and for the treatment of EGFR related diseases and disorders such as cancer.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: November 10, 2020
    Assignee: ZHEJIANG JIANFENG-YIEN BIOTECHNOLOGY CO., LTD.
    Inventors: Haixiao Zhai, Fan Wu